Trials / Conditions / Non-small Lung Cancer
Non-small Lung Cancer
7 registered clinical trials studyying Non-small Lung Cancer — 3 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Not Yet Recruiting | A Phase II Clinical Study of SKB571 as Monotherapy in Patients With Locally Advanced or Metastatic Non-Small C NCT07308106 | Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. | Phase 2 |
| Not Yet Recruiting | Real-world Study of Taletrectinib in Advanced ROS1+ NSCLC Following Entrectinib Progression NCT07199010 | Innovent Biologics (Suzhou) Co. Ltd. | — |
| Recruiting | A Study of Sotorasib in People With Non-Small Cell Lung Cancer NCT06582771 | Memorial Sloan Kettering Cancer Center | Phase 2 |
| Active Not Recruiting | Toripalimab Combined With SBRT for NSCLC NCT06293690 | Shanghai Pulmonary Hospital, Shanghai, China | Phase 2 |
| Completed | Safety and Efficacy of Neoantigen-Based Personalized Immunotherapy as Consolidation Therapy After Standard Adj NCT07504484 | Ying Yuan, MD | Phase 1 |
| Terminated | Genomic Landscape of Ceritinib NCT02554591 | Washington University School of Medicine | — |
| Terminated | Afatinib Genomic Landscape NCT02491775 | Washington University School of Medicine | — |